Annual report pursuant to Section 13 and 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.22.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net loss $ (11,472) $ (812) $ (7,334)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 661 730 431
Stock-based compensation 3,273 584 378
Loss on sale of property and equipment 0 127 0
Change in fair value of warrants 762 86 24
Founders notes forgiven 459 0 0
Transaction costs allocated to warrants 2,750 0 0
Non-cash interest expense 0 22 0
Changes in operating assets and liabilities      
Increase in trade receivables, net (618) (8,372) (5,174)
(Increase)/ decrease in prepaid expenses and other assets (1,823) 78 (546)
Increase/ (decrease) in trade payables 1,500 (545) 721
Increase in employees and payroll accruals 1,236 1,914 1,579
Increase in accrued expenses and other liabilities 851 2,029 939
Net cash used in operating activities (2,421) (4,159) (8,982)
Cash flows from investing activities:      
Internal use software capitalization (2,594) 0
Purchase of property and equipment (549) (1,030) (1,657)
Founders’ note receivable (459) 0 0
Proceeds from sale of property and equipment 0 6 0
Acquisitions of businesses, net of cash acquired 0 0 (4,232)
(Increase)/ decrease in deposits (85) 76 (333)
Net cash used in investing activities (3,687) (948) (6,222)
Cash flows from financing activities:      
Proceeds from reverse recapitalization, net* [1] 149,252 0 0
Capital contributions 0 504 0
Proceeds from issuance of preferred stock, net 0 0 29,692
Proceeds from loans 0 15,516 0
Loan repayment (3,033) (6,504) (6,000)
Repayment of acquisition liability (126) (592) 0
Proceeds from exercise of options 1,081 78 99
Net cash provided by financing activities 147,174 9,002 23,791
Increase in cash, cash equivalents and restricted cash 141,066 3,895 8,587
Cash, cash equivalents and restricted cash at the beginning of the year 16,092 12,197 3,610
Cash, cash equivalents and restricted cash at the end of the year 157,158 16,092 12,197
Supplemental disclosure of cash flows activities:      
Income taxes paid, net of tax refunds 535 421 208
Interest 259 272 328
Non-cash transactions      
Conversion of redeemable convertible preferred stock into common stock 164,060 0 0
Conversion of Legacy Innovid Warrants 5,080 0 0
Accrued acquisition liability 0 126 718
Accretion of preferred stocks to redemption value 77,063 7,297 2,007
Accrued transaction cost, not yet paid 3,185 0 0
Reconciliation of cash, cash equivalents, and restricted cash reported within the statement of financial position      
Cash and cash equivalents 156,696 15,645 11,641
Long-term restricted deposits 462 447 416
Restricted cash in prepaid expenses and other current assets 0 0 140
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows $ 157,158 $ 16,092 $ 12,197
[1] * Refer to Note 5 for details